featured
Association Between Fracture Risk and SGLT2 Inhibitors in Patients With Type 2 Diabetes Across eGFR and Albuminuria Categories
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Research and Clinical Practice
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Fracture risks associated with sodium-glucose cotransporter 2 inhibitors in type 2 diabetes patients across eGFR and albuminuria categories: a population-based study in Hong Kong
Diabetes Res. Clin. Pract. 2023 Feb 11;[EPub Ahead of Print], D Tak Wai Lui, T Wu, E Ho Man Tang, I Chi Ho Au, C Ho Lee, Y Cho Woo, K Choon Beng Tan, C King Ho WongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.